Hepatic GPR125: ligands and liver repair
肝脏 GPR125:配体和肝脏修复
基本信息
- 批准号:10452011
- 负责人:
- 金额:$ 15.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:ARNT geneAdhesionsAdultAgonistBile AcidsBile fluidBiological AssayCell LineCell MaintenanceClustered Regularly Interspaced Short Palindromic RepeatsCoupledCuesDevelopmentDietDiseaseDrug TargetingEnergy-Generating ResourcesEnvironmentEpithelial CellsExtracellular MatrixFDA approvedFamilyFemaleFunctional Magnetic Resonance ImagingFutureG-Protein-Coupled ReceptorsGene FamilyGenomeGlucoseGuide RNAHealthHepaticHomeostasisHormone ReceptorHumanHuman bodyImageImmunofluorescence ImmunologicInjuryIntercellular JunctionsInvestigationKnock-outKnockout MiceLeadLigandsLinkLiverLiver RegenerationMaintenanceMediatingMetabolicModelingMusMutateN-terminalNPBWR1 geneNatural regenerationNatureOrganOrphanPathway interactionsPharmacologyPhysiologicalPhysiologyPlayProcessReportingSensorySensory ReceptorsSiteStressTaste BudsTestingTissuesTransmembrane DomainXenobioticsZebrafishactivation-induced cytidine deaminaseadenoviral-mediatedadhesion receptorbasolateral membranebile ductcholangiocyteinjury and repairinterestknock-downliver functionliver injuryliver repairmalemanmemberolfactory receptorplanar cell polaritypreclinical developmentpreventreceptorregeneration following injurytissue repair
项目摘要
Project Summary
G protein-coupled receptors (GPCRs) are 7 transmembrane domain proteins that aid in the maintenance of
homeostasis by responding to cues produced by the internal and external environment. In humans, there are
more than 800 known GPCRs, and while more than 20% of all FDA-approved drugs target GPCRs, the vast
majority of these receptors are understudied. In fact, many of these uncharacterized ‘orphan’ receptors,
termed GPRs, are expressed at extremely high levels in different tissues suggesting that they likely have
important, yet unknown, physiological functions. The liver is the largest metabolic tissue in the human body
and is responsible for a number of important functions including sensing and detoxifying xenobiotics,
metabolizing glucose and other energy sources, and synthesizing and secreting bile acids. Thus, it is well-
poised to take advantage of some sensory GPRs to aid in these processes. We recently identified a total of 57
GPRs that are expressed to varying degrees in the murine liver, including 7 with expression profiles that rival
other well characterized receptors. One of these high expressing receptors is adhesion receptor GPR125
(ADGRA3). As a family, adhesion receptors have been linked to the maintenance of cell-cell junctions and
have been reported to be activated by proteolytically cleavage of their non-covalently attached N-terminal
domain. However, GPR125 is an atypical adhesion receptor with a mutated cleavage site and it is unclear if
this receptor is activated via the conventional processes. GPR125 has been linked to the development of
planar cell polarity in a Zebrafish model suggesting that this receptor may be involved in tissue repair in adult
tissues. Using RNAscope and immunofluorescence, we have localized GPR125 to the basolateral membrane
of cholangiocytes. Lining the bile ducts, cholangiocytes play a key role in the liver regeneration following
injury. Thus, GPR125 is uniquely suited to contribute to this process. We hypothesize that GPR125, on the
basolateral membrane of cholangiocytes, is activated by components of the extracellular matrix in order to
contribute to liver repair following injury. This will be tested using the PRESTO-TANGO assay to deorphanize
the receptor alongside a unique liver-specific knockout mediated by adenoviral delivery of CRISPR guide
RNAs. Collectively, our discoveries will unveil new functions for a highly expressing, yet under-characterized,
receptor and will set the stage for future physiological analysis in both mouse and man.
项目摘要
G蛋白偶联受体(GPCR)是7个跨膜结构域蛋白,其有助于维持G蛋白偶联受体的功能。
通过对内部和外部环境产生的线索做出反应来保持体内平衡。在人类中,
超过800种已知的GPCR,虽然超过20%的FDA批准的药物靶向GPCR,
这些受体中的大多数都未被充分研究。事实上,许多未被鉴定的孤儿受体,
在不同的组织中以极高的水平表达,这表明它们可能具有
重要但未知的生理功能肝脏是人体内最大的代谢组织
并负责许多重要的功能,包括感应和解毒异生物质,
代谢葡萄糖和其他能量来源,并合成和分泌胆汁酸。因此,这是很好的-
准备利用一些感觉GPR来帮助这些过程。我们最近一共确认了57名
在小鼠肝脏中不同程度表达的GPR,包括7种表达谱与
其他特征良好的受体。这些高表达受体之一是粘附受体GPR 125
(ADGRA3)。作为一个家族,粘附受体与细胞-细胞连接的维持有关,
已报道通过蛋白水解切割它们非共价连接的N-末端
域然而,GPR 125是一种具有突变切割位点的非典型粘附受体,
该受体通过常规方法活化。GPR 125与以下方面的发展有关:
斑马鱼模型中的平面细胞极性表明该受体可能参与成体组织修复
组织中利用RNA显微镜和免疫荧光技术,我们将GPR 125定位于基底外侧膜
胆管细胞胆管细胞排列在胆管中,在以下肝再生中起关键作用:
损伤因此,GPR 125是唯一适合于促进这一过程。我们假设GPR 125,在
胆管细胞的基底外侧膜,被细胞外基质的成分激活,
有助于损伤后的肝脏修复。这将使用PRESTO-TANGO检测试剂盒进行检测,
该受体与由CRISPR引导的腺病毒递送介导的独特的肝脏特异性敲除一起
RNA。总的来说,我们的发现将揭示一个高度表达,但特征不足,
受体,并将为未来的生理分析在小鼠和人的阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Blythe D Shepard其他文献
Blythe D Shepard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Blythe D Shepard', 18)}}的其他基金
Elucidating the Role of Olfactory Receptor 1393 in Renal Glucose Handling
阐明嗅觉受体 1393 在肾葡萄糖处理中的作用
- 批准号:
10440017 - 财政年份:2016
- 资助金额:
$ 15.6万 - 项目类别:
Renal Olfactory Receptor 1393: Ligands, Localization and Function
肾嗅觉受体 1393:配体、定位和功能
- 批准号:
8397867 - 财政年份:2012
- 资助金额:
$ 15.6万 - 项目类别:
Renal Olfactory Receptor 1393: Ligands, Localization and Function
肾嗅觉受体 1393:配体、定位和功能
- 批准号:
8700391 - 财政年份:2012
- 资助金额:
$ 15.6万 - 项目类别:
Renal Olfactory Receptor 1393: Ligands, Localization and Function
肾嗅觉受体 1393:配体、定位和功能
- 批准号:
8511352 - 财政年份:2012
- 资助金额:
$ 15.6万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 15.6万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 15.6万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 15.6万 - 项目类别:














{{item.name}}会员




